Final Faculty Set for 2nd Annual PRIMO Meeting

The final faculty is set for the 2nd Annual Practical Recommendations in Immuno and Molecular Oncology (PRIMO) Meeting this upcoming February in Maui. 2017’s faculty features both returning and new faces, all of whom are top experts in their respective fields.

Your official faculty of the 2nd Annual PRIMO Meeting are:

Co-chairs

Julie R. Brahmer, MD, MSc – Associate Professor of Oncology; Director, Thoracic Oncology Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland.

Julie M. Vose, MD, MBA – Neumann M. and Mildred E. Harris Professor; Chief, Division of Oncology/Hematology, University of Nebraska Medical Center, Omaha, Nebraska.

 

Faculty

Sanjiv S. Agarwala, MD – Professor of Medicine, Temple University; Chief, Medical Oncology/Hematology, St. Luke’s Cancer Center, Bethlehem, Pennsylvania.

Farrukh T. Awan, MBBS, MS – Associate Professor of Internal Medicine, Division of Oncology, the Ohio State University Comprehensive Cancer Center, Columbus, Ohio.

Charles M. Balch, MD, PhD (hc) – Professor of Surgery, University of Texas, Southwestern Medical Center, Dallas, Texas.

Clayton Chong, MD, MPH – Chief of Oncology, the Queen’s Medical Center, Honolulu, Hawaii.

Naval Daver, MD – Assistant Professor, Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, Texas.

Elliot Epner, MD, PhD – Medical Oncologist, North Hawaii Community Hospital, Kamuela, Hawaii.

Rafael Fonseca, MD – Getz Family Professor of Cancer; Chair, Department of Medicine, Mayo Clinic, Scottsdale, Arizona.

Julie R. Gralow, MD – Jill Bennett Endowed Professor of Breast Cancer; Director, Breast Medical Oncology, University of Washington, Seattle, Washington.

Leora Horn, MD, MSc – Associate Professor of Medicine; Assistant Director, Education Development Program; Clinical Director, Thoracic Oncology Research Program, Vanderbilt University Ingram Cancer Center, Nashville, Tennessee.

Sara A. Hurvitz MD – Associate Professor of Medicine; Director, Breast Oncology Program; Medical Director, Clinical Research Unit, UCLA Medical Center, Santa Monica, California.

Sagar Lonial, MD – Professor, Department of Hematology and Medical Oncology; Chief Medical Officer, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia.

Ravi A. Madan, MD – Clinical Director, Geniturinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.

Shane Y. Morita, MD, MS, PhD, FACS – Director, Surgical Oncology Program, the Queen’s Medical Center, Honolulu, Hawaii.

Paul Morris, MD, FACS, FCCP – Cancer Committee Chair, the Queen’s Medical Center, Honolulu, Hawaii.

Rita Nanda, MD – Associate Professor of Medicine; Associate Director, Breast Medical Oncology, University of Chicago Medical Center, Chicago, Illinois.

Suresh S. Ramalingam MD – Professor of Hematology and Medical Oncology; Roberto C. Goizueta Chair for Cancer Research; Assistant Dean for Cancer Research; Deputy Director, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia.

Hope S. Rugo, MD – Professor of Medicine; Director, Breast Oncology and Clinical Trials Education, USCF Helen Diller Family Comprehensive Cancer Center, San Francisco, California.

Tanguy Seiwert, MD – Assistant Professor; Associate Director, Head and Neck Cancer Program, University of Chicago, Chicago, Illinois.

Mazyar Shadman, MD, MPH, Assistant Professor, Medical Oncology Division, University of Washington School of Medicine; Assistant Member, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

Alan P. Venook, MD – Professor of Medicine; Shorenstein Associate Director for Program Development, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California.

Jack West, MD – Medical Director, Thoracic Oncology Program, Swedish Cancer Institute; Founder and President, Global Resource for Advancing Cancer Education (GRACE), Seattle, Washington.

Kit Wong, MD, Assistant Professor, University of Washington School of Medicine; Assistant Member, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

 

PRIMO is ecstatic to have secured such an elite faculty, and is thankful for all the hard work everyone has put in to ensure that 2nd Annual PRIMO Meeting is even more exceptional than last year.

 

To keep up with the latest PRIMO news, please follow us on social media: LinkedIn, Twitter, Facebook.

2 responses to “Final Faculty Set for 2nd Annual PRIMO Meeting

Leave a Reply

Your email address will not be published. Required fields are marked *